Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yeah that's fair. I was just going kg to lbs and picked 2g/lb and said "under 5$/gram" --- but yes you're right everything is gram for gram ranging from 5-12$ etc etc. Was trying to be conservative but yes I totally effed up the math ;).
Been around CGC and others since inception, so I am definitely aware of what we've got here and I apologize for the misinformation!
We're all on the same team though, I agree. Thanks!
Enjoy the remains of your weekend!!
just trying to help - I would hate for someone to completely misunderstand what they are invested in, and you are welcome
and 12k kgs @ 5 is EXACTLY $60 mil, they are produced in grams, sold in grams, no pounds necessary
Sorry, was a late night. say $2,000/lb x 26,400lbs.. = you're right. Nearly 53m
They can grow you buds, but not a welcoming personality. Thanks for the correction, however. See ya 'round $20 next Spring.
12,000 kg at $5 a gram is only $60 million - you are off by a couple of orders of magnitude. I recommend traders good a good grip on both arithmetic and the metric system before moving on to financial markets
I guess the IPO for Emblem is already closed but you can be added to a wait list.
What do you guys think of Emblem. Not trying to say their good bad or in-between just want to see what everyone has found on them. Their IPO is November 19th. Sure their facilities are not as big as others but it is a new industry with years to come. I've found their IPO price is going to be around 1.25 a share. Have a 23,000 square foot grow op and our seeking to expanded it. SO what have you guys found or what are your opinions. Currently plan on keeping a close eye on it.
The magnitude of this statement in CGC latest news release is undeniable a historic 12 kilo moment :
This current harvest that is underway as we speak will be the first time we've used the full potential of the largest greenhouse in the industry and we're very excited to bring a harvest of this scale to market for medical cannabis patients."
With this license extension, Canopy Growth Corporation has a present licensed production capacity of 12,000 kg across three diversified, world-class sites.
I think that places like Shoppers will provide weed from large-scale LPs and give everyone variety.... No more having to pick between signing up with CGC over Aphria, for example. You get to go to shoppers and have your pick, as long as you have a valid prescription.
This is going to add an awesome convenience factor... And allow LPs to put more product out the door and get better exposure too.
Imagine what a signed deal with Shoppers would look like.... Fill up a drug store with CGC weed. Bedrocan underneath the Canopy will also help to put this stuff in action....
They were the first to pioneer MMJ in the Netherlands. Smart move for CGC.
How can the Gov allow these grey area dispensaries and say "No" to Shoppers? This is gonna be huge fellas.....
20$ by next summer could be a real conservative bet here.... These revenues are peanuts compared to where the whole sector is going. Aim for the big LPs and you won't go wrong holding long IMO.....
Well I figure revenues are super low in the sector to start off.... 12,000kg CGC is approved for between 3 facilities..... Capacity there would be over 2 billion in revenue at $2,000/lb or under 5$ per gram....
Not sure on the time frame but things like this get me excited.... Health Canada granted these mega licenses and now we are looking to distributors... Where is the weed coming from? CGC, Aphria, Mettrum, Tilray, etc etc etc..... That's my thoughts. Check this out. Shoppers does not want to produce Cannabis but they want to distribute:
www.theglobeandmail.com/report-on-business/shoppers-drug-mart-applies-to-be-medical-marijuana-distributor/article32511374/?arc404=true
What time frame do you give for it to get to 20 bucks a share
Just bought 1k shares LOVE This STOCK
Why you mad... Go invest in them if you feel that confident
BAYER and MONSANTO will crush these small time green thumbs once they get into the market and make GMO marijuana
Also here for the long run so just hoping for the best
I think it will go above 20. But trade on your timeline right! I am going to be here for a very long time regardless.
You think it will go above 10?
Relying on courier services to get product to customers may have its drawbacks if legislation changes the recreational and retail guidelines for MJ in Nov
Be careful. Overbought...maybe price won't react too badly to when it consolidates, but it WILL consolidate.
You honestly think CGC is worth 3/4 of a million dollars??
Oh yeah? Please, tell us more!
Unless there's oxycodine and OxyContin?meh what do I know
I think you have spell trouble yourself wtf is Oxycontin?
CGC downgraded to hold by M Partners, on valuation.
Look you missed youre chance accept it and move on go invest in emblem the 24000sq ft mega grow
Emblem has nothing on CGC.... Would not put $ into a non-revenue LP with no license to sell and a mere 23,000 ft of grow space. Insignificant baby grower underneath the umbrella of the venture-capital outfit, KindCann.
Not seeing the Oxy connection either.
Can't compare to the revs that CGC and APH are bringing in... Emblem has no competitive advantage and with a piddly facility and without a license to sell it is not even an attractive take-over target.
SL/SPRWF is further along, waiting for a license to sell (like Emblem) and has 400k sqft of greenhouse space...
There are some potential "disruptive" competitors, in my opinion, but they will be absorbed by the larger entities with cash to spend.
GL!
Go CGC!
So many competitors, including the developer of Oxycontin named Emblem which will have an IPO in November. Big Pharma capital and experience in the business will be a tough competitor!!! If they end up on Health Canada's good side it will spell trouble for CGC
Agreeed on Aphria!
I think that several competitors are undervalued but that CGC is positioned very well... They are doing away with older strains too, and are adopting new genetics... They've got the cash to acquire the smaller fish, too, and are becoming an international player.
Not overvalued simply because some others are 1/2 the price. First-mover advantage turned out to be bigger than anyone imagined 3 years ago.... And the Bedrocan acquisition --plus partnerships & funding going to MADD-- makes CGC especially attractive because of its political backdrop as well...
If folks disagree -- feel free to take profits -- but I suspect double digits here before a Rec market, and a parabolic move into a Rec market with CGC paying a dividend in the future.
Those who bought at 1.50 and 2.00 are looking good right now.
And with that said... I am in several other smaller players that will also be big movers.
$$$$$$$$$$ CGC $$$$$$$$$$
CGC has the capacity to evolve with the demands of the market whether it's med or rec we will dominate.
Don't believe me ? Take a minute and visit their site ? Still not convinced just focus on the chart ! Boom $ !
Careful with that buy button upcoming major catalyst via Canadian legislation reform will cause huge impact on PPS.
Also, recent price increases on Bedrocan strains from $5 to $6.50 indicate CGC's operations are not as profitable as you might expect.
Exactly APH is up on its way. Overvalued
Overvalued, so much competition out there- makes this a very risky sector. After all, cannabis is a commodity and everyone knows that being in the commodity business is very treacherous.
I'm also long ACB /ACBFF and SL / SPRWF.... Hoping they follow suit soon.
Go CGC!
Nice buy! It's a great one.... I got my dad in a few years back... He avgd all the way down to 1.70 cdn when it dipped hard.... Hasn't sold a share yet either.
Gonna be 20$ a share no problem...imo...
I could not be happier with this stock. I got 12k of USA shares at 2.50. I'm long for 5 years. It's flying today
Yup! Easy 10$ a share before the year's out..... And we'll just keep getting stronger.
CGC to be the Molson-Coors of MJ!
Amazing resistance was overcome hello 6.00 +++
Once we get past 5.80 $6.00 is going to come fast !
Im sure glad Im not watching the board and complaining about profits ..,ha ha I much prefer making profits and holding CGC shares and making $$$$
Agreed they have a long way to go before profits are shown. That's why big banks backed out , no revenue = a big no for institutions
# CGC: Best advice for everyone.
# CGC : Great DD post Blazing...
I dont get it.. Either you hate money or youre half retarded...
ok then don't invest sit back and watch the chart burn a hole through the top of your screen ... I have been following tweed since its inception and without a doubt I can say no other MJ company has worked so hard and diligently to increase shareholder value slow and steady and now it's paying off for us.
On Monday I'm gonna eat turkey and count money and Thanksgiving is going to be a big thank you CGC for giving me money day!
Profits that count are the ones in your pocket remember that$
Compared to the other licensed producers in Canada, and even many MMAR growers, no they are not producing the highest quality medicine. There are no producers as big, but there are better ones and profitable ones!
BA ha ha ha! I see you've done no homework. The Canadian government enforces the strictest rules when granting licenses and there is no doubt CGC is selling the highest quality medical mj ever produced.
And by the way CGC has assembled the most educated board on a MJ corps team ever ever in history this is unprecedented and this is for real.
No No it's not one person behind CGC my friends, have a look:
OUR CORE BRANDS
Tweed is the most recognized marijuana production brand in the world. It has built a large and loyal following by focusing on quality products and meaningful customer relationships. Tweed doesn’t just sell marijuana, it facilitates a conversation about a product we’ve all heard about but haven’t met intimately yet. It is approachable and friendly, yet reliable and trusted. As marijuana laws liberalize around the world, Tweed will expand its leading Canadian position around the globe.
Bedrocan is the epitome of medical-grade cannabis. Bedrocan BV pioneered medical cannabis in Holland through decades of selection and refinement, leading to standardized, whole bud cannabis strains that patients can rely on. Bedrocan Canada supplies the same standardized strains to the Canadian market through exclusive licensing rights to the American continents, an arrangement it will also enjoy for all future genetic advancements. Due to its consistency over time, Bedrocan’s strains have been used in clinical research in seven European countries. That commitment to research didn’t stay on the east side of the Atlantic – Bedrocan Canada recently launched one of the largest clinical cannabis studies in the world, the EQUAL Study, to evaluate quality of life before and after medical cannabis use.
OUR DIVERSIFIED GROWING PLATFORMS
DATA DRIVEN INDOOR PRODUCTION
Tweed is housed in the famous former Hershey Chocolate factory at 1 Hershey Drive, the campus comprises 40 acres of land with over 500,000 sq. ft. of available space. Tweed occupies 168,000 sq. ft. of licensed production space, plus office space where Canopy’s head office drives the vision forward. It is a data-driven, automated and lean operation, housing an R&D facility, oil extraction infrastructure, and in-house lab. Precise climate controlled spaces for each stage of cannabis production, from clone to cured bud, allows for the highest quality and widest variety of product in the sector.
REFINED STANDARDIZED HARVESTS
Bedrocan Canada operates to the refined and unwavering processes developed over decades in the Netherlands. At over 50,000 square feet, no variable is left unchecked to ensure the stabilized genetics produce standardized harvests time and time again. A second facility serves as a distribution-only location, where product imported from the Netherlands has historically been distributed to the Canadian market.
GREENHOUSE GROWN
Tweed Farms is the largest marijuana-producing greenhouse in the world, certainly legally that we’ve ever come across, with over 350,000 square feet of licensed cannabis production space. The scale and the passive processes allow the Farm to produce environmentally friendly cannabis at extremely competitive cost per gram. The Farm combines traditional and state-of-the art agricultural techniques, using the natural power of the sun and recycled rainwater to nurture genetically identical plants produced in the on-site tissue culture propagation lab.
OUR CORE PARTNERS AND FRIENDS.
Snoop Dogg is one of the most revered figures in music, entertainment and more recently, a business pioneer in the cannabis sector. Over a respected career that stretches 25 years, his repertoire has turned him into a cultural icon across mediums. Snoop and business partner Ted Chung recently launched online media platform MERRY JANE, the definitive cultural destination for news and original content. He is also the first celebrity to release a branded line of products, “Leafs By Snoop,” which includes hand-weighed flower, concentrates, and edibles. Via Casa Verde Capital, Snoop has also made a foray into the venture capital model for early stage start-ups. Tweed is pleased to partner with Snoop, a true global powerhouse.
DNA Genetics have won awards in every category in the Cannabis Cup, the world’s preeminent cannabis competition. They are, simply put, global breeding and growing legends. DNA has partnered with Tweed to ensure all that knowledge and experience is put to good use as Tweed and Tweed Farms continue to iterate through their growing and curing processes to arrive at nothing short of perfection. Working with DNA, Tweed will be breeding new strains for customers that simply aren’t available anywhere else in the world, and bringing the best of existing DNA genetics to Tweed customers, bred and grown to the DNA standards the world expects.
Driven by a leadership team consisting of former legislators, public health experts, and medically-focused entrepreneurs, AusCann is a leader in Australia's emerging medical cannabis industry. Working with Canopy's subsidiaries Tweed and Tweed Farms, AusCann is in the process of developing world-class production standards that they will use to grow clean, consistent medical strains. Australian patients will have access to a wide array of AusCann products in 2017.
Indoor Harvest is developing aeroponic agriculture solutions for the cannabis industry. The Texas-based company is already working with CityFarm at the Massachusetts Institute of Technology (MIT) to revolutionize the efficiency and accessibility of agriculture. Working with Tweed’s R&D team, Indoor Harvest is developing IP that both companies can leverage and license throughout the world.
CannScience is an R&D biopharmaceutical company established to conduct research and development of therapeutic products based on the extracts from medical cannabis. CannScience is developing proprietary technologies that will be the future of medical cannabis delivery, and through its 33% stake in the company, Canopy is happy to be along for the ride.
THE TEAM
Our accomplishments to date are a result of our diversity. From horticultural experts to storied cannabis growers – Harvard MBAs to Cambridge law graduates – Ottawa Valley tech icons to Compassion Club pioneers. With no existing roadmap to success in the cannabis sector Canopy created its own, valuing IQ along with expertise, bringing together the types of people who go looking for opportunities to innovate. We were the first cannabis company to go public, the first to launch diversified growing platforms, and the first to bring together two major licensed cannabis producers under one roof.
We are proud of our accomplishments, and are always looking for the next first.
Here’s to Future Growth.
BOARD OF DIRECTORS
The Board of Directors of Canopy Growth Corp. provides the leadership and oversight needed to forge an industry leader in an emerging industry. The Board is fully committed to our stakeholders and shareholders, leveraging decades of collective corporate governance experience to provide stability and growth over the long term.
BRUCE LINTON - CHAIRMAN AND CHIEF EXECUTIVE OFFICER
Mr. Linton is the founder of Canopy Growth Corporation (CGC) and co-founder of Tweed Marijuana Inc. Bruce’s primary focus has been to position cannabis brands in a competitive market and to raise the capital necessary to fund such operations. Bruce’s experience as a founder, CEO, and Board member across a wide variety of enterprises has influenced the positive start of Canopy Growth, which to date has enjoyed market support for capital raises of approximately $95 million and the distinction of being the first company in the industry to be offered debt instruments by a federal lender. Bruce has led three M&A transactions valued over $70 million total since founding CGC. In addition to his leadership responsibility at Canopy Growth, Bruce is the CEO of communications company Martello Technologies. After beginning his career at Newbridge Networks Corporation, he has since held positions that include General Manager and Re-Founder of Computerland.ca, President and Co-Founder of webHancer Corp, and part of the establishing team at CrossKeys Systems Corporation. He was also part of the leadership team for the Nasdaq/TSX initial public offering at CrossKeys. Bruce has been responsible for the acquisition and/or disposition of over $200 million in business assets, and has established regular engagement with the World Bank and Asia Development Bank while focused on markets in India, Philippines, China, Peru, Colombia, Ecuador, Azerbaijan and Uzbekistan. Bruce led the successful entry of both CrossKeys and Clearford into the Chinese market. In 2009 Clearford was awarded by the Canada-China Business Council for its market entry strategy. Bruce sat as Canada’s representative on the World Bank’s Water Sanitation Program. He has been on the Cleantech Advisory Board for Foreign Affairs, Trade and Development Canada. He is the past Chairman of the Ottawa Community Loan Foundation, past Board Member and Treasurer of Canada World Youth past Board of Governor for Carleton University, past President of the Nepean Skating Club and past President of the Carleton University Students Association.
JOHN K. BELL, CPA, FCA, ICD.D - DIRECTOR
Mr. Bell founded Shred-Tech and grew it into a global giant in the mobile document shredding and recycling industry. After selling Shred-Tech in 1995, he purchased Polymer Technologies and grew it from a local plastics manufacturer to a global auto parts company before exiting in 2007. John also served as interim CEO and director of ATS Automation (TSX), which operates 24 global manufacturing facilities, has 4,000 employees and $700 million in sales during a time of management and board renewal in 2007. John was the lead investor and Chairman of BSM Wireless (TSX-V). First investing in 2006, he led board and management renewal leading to substantial and profitable growth before successfully exiting in 2014. John also sits on the Board of Strongco Corp, traded on the Toronto Stock Exchange as SQP and DelMar Pharmaceuticals, which is traded on OTCQX as DMPI.
PETER STRINGHAM - DIRECTOR
Mr. Peter E. Stringham recently retired as Chairman and Chief Executive Officer of The Young & Rubicam Group Of Companies. Mr. Stringham served as the Chief Executive Officer of Young & Rubicam Brands at Young & Rubicam, Inc. since March 2, 2007. Mr. Stringham served as Group General Manager of Marketing of HSBC Holdings PLC. and HSBC Bank plc. since 2001. He served as Head of Global Marketing for HSBC Holdings plc. until March 2007. He joined HSBC in 2001. He served for 6 years at HSBC, where he was instrumental in positioning it as the 'world's local bank' in a series of local advertising and marketing campaigns, and has helped build HSBC into one of the world's most recognized brands. He consolidated HSBC's advertising and marketing duties with a single lead worldwide marketing services group. He served with WPP Group to cover HSBC's operations in 76 countries and territories.
MURRAY GOLDMAN - DIRECTOR
Mr. Goldman, is the former Chairman of Bedrocan Canada Inc. and joined the Board of Directors when Bedrocan was successfully acquired by Canopy Growth. Mr. Goldman is the founder and Chairman of The Goldman Group, a fully integrated real estate development company that has developed and built in Canada, the United States and Israel for over 50 years. The company has a history of innovative and original mixed-use developments that have established precedent- setting neighbourhoods in the Greater Toronto Area. In 2010, Mr. Goldman received the NAIOP lifetime achievement award acknowledging his leadership in this field. Mr. Goldman continues to serve as a director of a number of prominent organizations and is a major investor and founder of a number of innovative medical and scientific research companies.
CHRIS SCHNARR, ICD.D - DIRECTOR
Mr. Schnarr is the President and Chief Financial Officer at Delivra Inc., a company involved in the development and sale of transdermal products and technologies for the topical delivery of pharmaceutical and natural molecules. Mr. Schnarr has 25 years of experience founding, managing, and advising growth companies, including strategy, corporate finance, capital markets, corporate development, M&A, financial reporting, and governance. His functional experience across executive positions spans Treasurer, Executive Vice President, Chief Financial Officer, President, and Chief Executive Officer. His broad industry experience includes technology (hardware, software, and services), communications, agriculture, food processing and food ingredients, financial services, health care, and sustainability. Mr. Schnarr has 18-years of public company Board experience across TSXV and TSX listed companies, as well as extensive committee experience. He is presently a Director and Chair of the Audit Committee and member of the Governance and Compensation Committees of Legumex Walker Inc. (TSX:LWP) and a Director and Chair of the Audit Committee and a member of the Compensation and Governance Committee at Intrinsic 4D Inc. (TSX:V).
Mr. Schnarr holds a Masters in Business Administration (finance) from University of British Columbia (1990), and a Bachelor of Business Administration degree with a Minor in Economics, from Wilfrid Laurier University (1989). He is a member of the Institute of Corporate Directors, a graduate of the Directors Education Program at the Rotman School of Business at the University of Toronto, and holds the ICD.D designation.
What they really need is profitable revenue. All those revs aren't so great when you consider how much money they are burning through. Shit weed that nobody is going to want to smoke if it isn't through mail order...
I don't doubt this company will get to $10 stock price. But I think long term they need to step up their acts.
Company founded by someone who never smoked weed. No passion just money...
Maybe if they throw money at a cactus it will make them more profits
The true excitement hasnt even begun yet
$$$CGC$$$
That's the honest truth brother 5k will be 50k in record time !
Followers
|
134
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
72
|
Created
|
09/29/16
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads